ISO 13485 and CE Certified
Effective detection of variants
Results in 15 mins
Soft Nasal Swab
Trusted by the Medical System
Nasal and nasopharyngeal swab
SARS-CoV-2 Nucleocapsid protein
20 tests/ box (individually packed)
1 test/ box
CO-Check COVID-19 Rapid Antigen Test is a lateral flow immunoassay intended to be used as an aid for diagnosis by the qualitative detection of nucleocapsid antigen from SARS-CoV-2 in nasal swab from symptomatic individuals who are suspected of COVID-19 infection within 7 days of symptom onset.
Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in nasal swab during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions. Negative results should be considered in the context of a patient's recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with molecular assay, if necessary, for patient management.
Faster results equals faster treatment.
Our mission is to provide affordable, reliable and rapid frontline diagnosis solutions to individuals and frontline healthcare professionals to enable faster treatment and prevent further spread of the COVID-19 virus.